Cleveland HeartLab, Inc. logo

Cleveland HeartLab, Inc.

Specializing in next-generation cardiovascular disease prevention, diagnosis & management and inflammation testing.

63 employees · est. 2000 · Cleveland, United States

VS
Mirnext logo

Mirnext

Pioneering the future of cardiovascular health with innovative miRNA biomarkers to enhance diagnosis and clinical management of heart-related conditions.

est. 2012

Cleveland HeartLab, Inc. is the older company (2000 vs 2012).

Side-by-Side Comparison

Cleveland HeartLab, Inc. Mirnext
Founded
2000 older 2012
Headquarters
Cleveland, United States Not tracked yet
Employees
63 Not tracked yet
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care, Health and Wellness
Funding Stage
Series Unknown Series Unknown
Total Funding
$48.05M Not tracked yet
Funding Rounds
6 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cardiovascular Disease Prevention, Diagnosis, Management, Inflammation Testing, Clinical Reference Laboratory, Biomarkers, Risk Assessment, Heart Disease, Cardiac Events, Inflammation Management, Advanced Testing, Healthcare Innovation, Diagnostics, Medical Technology, Precision Medicine Biomedical Company, MiRNA Biomarkers, Cardiovascular Health, Diagnostic Procedures, Clinical Management, Heart Failure, Coronary Artery Disease, Myocardial Infarction, Predictive Markers, Multi-marker Tests, Amsterdam, Netherlands
Website
clevelandheartlab.com mirnext.com
Cleveland HeartLab, Inc. logo

About Cleveland HeartLab, Inc.

Cleveland HeartLab, Inc. is a leading Clinical Reference Laboratory focusing on next-generation cardiovascular disease prevention, diagnosis, and management. Founded in 2000 and headquartered in the United States, the company specializes in offering a reliable and affordable group of biomarkers that...

Mirnext logo

About Mirnext

Mirnext is a pioneering biomedical company founded in 2012 that focuses on revolutionizing the future of cardiovascular health. Through the identification, validation, and commercialization of miRNAs, Mirnext aims to introduce innovative biomarkers for cardiovascular disease. These circulating miRNA...

We will tell you when either one moves

BounceWatch watches Cleveland HeartLab, Inc. and Mirnext for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cleveland HeartLab, In... and Mirnext — by email.

Frequently Asked Questions

Cleveland HeartLab, Inc. — Specializing in next-generation cardiovascular disease prevention, diagnosis & management and inflammation testing.. Mirnext — Pioneering the future of cardiovascular health with innovative miRNA biomarkers to enhance diagnosis and clinical management of heart-related conditions.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cleveland HeartLab, Inc. has raised $48.05M while Mirnext has raised undisclosed funding.
Cleveland HeartLab, Inc. and Mirnext operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cleveland HeartLab, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Cleveland HeartLab, Inc. on 12 Sep 2024, and Mirnext on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes